
Bing-yu Chen, Lu-xi Jiang, Ke Hao, Lu Wang, Ying Wang, Yi-wei Xie, Jian Shen, Meng-hua Zhu, Xiang-ming Tong, Kai-qiang Li, Zhen Wang. Protection of plasma transfusion against lipopolysaccharide/
@article{title="Protection of plasma transfusion against lipopolysaccharide/
author="Bing-yu Chen, Lu-xi Jiang, Ke Hao, Lu Wang, Ying Wang, Yi-wei Xie, Jian Shen, Meng-hua Zhu, Xiang-ming Tong, Kai-qiang Li, Zhen Wang",
journal="Journal of Zhejiang University Science B",
volume="19",
number="6",
pages="436-444",
year="2018",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B1700277"
}
%0 Journal Article
%T Protection of plasma transfusion against lipopolysaccharide/
%A Bing-yu Chen
%A Lu-xi Jiang
%A Ke Hao
%A Lu Wang
%A Ying Wang
%A Yi-wei Xie
%A Jian Shen
%A Meng-hua Zhu
%A Xiang-ming Tong
%A Kai-qiang Li
%A Zhen Wang
%J Journal of Zhejiang University SCIENCE B
%V 19
%N 6
%P 436-444
%@ 1673-1581
%D 2018
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B1700277
TY - JOUR
T1 - Protection of plasma transfusion against lipopolysaccharide/
A1 - Bing-yu Chen
A1 - Lu-xi Jiang
A1 - Ke Hao
A1 - Lu Wang
A1 - Ying Wang
A1 - Yi-wei Xie
A1 - Jian Shen
A1 - Meng-hua Zhu
A1 - Xiang-ming Tong
A1 - Kai-qiang Li
A1 - Zhen Wang
J0 - Journal of Zhejiang University Science B
VL - 19
IS - 6
SP - 436
EP - 444
%@ 1673-1581
Y1 - 2018
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B1700277
Abstract: fulminant hepatic failure is a severe clinical condition associated with extremely poor outcomes and high mortality. A number of studies have demonstrated the ability of plasma transfusion to successfully treat fulminant hepatic failure, but the underlying mechanisms are not well understood. The aim of the present study is to define the mechanisms of plasma transfusion treatment in lipopolysaccharide/
CLC number: Q291
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2018-05-14
Cited: 0
Clicked: 8044
Open peer comments: Debate/Discuss/Question/Opinion
<1>